Course: Expert Analysis of HER2-Low and HER2-Ultralow Updates to Pathology Practice
CME Credits: 1.00
Released: 2026-05-05
This expert-led CME activity explores key updates from American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines and the 2025 CAP Cancer Protocol for breast cancer (BC), focusing on human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow classifications. Our expert faculty will discuss how to interpret complex staining patterns, assess heterogeneity, and determine when repeat biopsy is warranted. Through real-world cases and faculty insights, pathologists will gain practical strategies for accurate HER2 reporting and understand how these classifications impact treatment decisions in patients with mBC.
Upon completion of this activity, participants should be better able to:
View Full Course